Hlavní strana Mezinárodní biotech události SMi’s 19th Annual Pain Therapeutics Conference

SMi’s 19th Annual Pain Therapeutics Conference

Copthorne Tara Hotel, London, UK (May 13-15, 2019)

SMi’s 19th Annual Pain Therapeutics Conference

Proudly sponsored by: CHDR, Lotus Clinical Research and MD Biosciences

The global opioids market size was valued at $22.96bn USD in 2016 and is projected to expand at a CAGR of 4.8% between 2018 and 2025. Rising prevalence of diseases that cause chronic pain, such as cancer, lower back pain, postsurgical pain, arthritis, and fibromyalgia, is driving growth.

Join Europe's leading Pain Therapeutics Conference, to explore the cutting-edge research of novel therapeutic targets in the pipeline of leading pharmaceutical companies and to discuss solutions for the challenges of clinical trial design and conduct.

The 19th annual conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, atypical opioids, migraine treatments, such as Lasmiditan and Aimovig, novel discoveries in opioid-free analgesia and the future forecast for pain therapeutics – industry leaders will uncover the latest advancements in the field. Furthermore, policy experts will provide an essential regulatory perspective for this year’s agenda, providing an exciting and comprehensive insight into the pain therapeutics market.

New case studies and regulatory perspectives will bring together the challenges and successes of both pre-clinical and clinical development to equip you with the necessary knowledge to advance the pain therapeutic industry.#SMiPainTherapeutics

WHO SHOULD ATTEND?

Chief Executive Officer, Chief Scientific Officers, Chief Medical Officers, Managing Directors, CEO, Head of Department, Principal Research Scientists, Clinical lead, Clinical Operations in the following fields: